Michael A Rogawski Selected Research

Gluk1 kainate receptor

8/2009	Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons.
6/2004	Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist.
6/2004	Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist.
4/2003	GluR5 kainate receptors, seizures, and the amygdala.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael A Rogawski Research Topics

Disease

48	Seizures (Absence Seizure) 01/2021 - 05/2002
36	Epilepsy (Aura) 01/2020 - 01/2002
17	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 01/2009
5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2003
4	Neuroinflammatory Diseases 12/2021 - 12/2014
4	Temporal Lobe Epilepsy 07/2017 - 08/2002
3	Epileptic Syndromes 01/2020 - 01/2007
3	Partial Epilepsies (Epilepsy, Partial) 01/2018 - 11/2007
3	Migraine Disorders (Migraine) 04/2012 - 07/2004
3	Infantile Spasms (West Syndrome) 11/2011 - 01/2002
3	Drug Resistant Epilepsy 09/2008 - 06/2002
2	Brain Injuries (Brain Injury) 12/2021 - 04/2014
2	Gliosis 11/2020 - 01/2020
2	Cognitive Dysfunction 01/2020 - 12/2019
2	Pain (Aches) 01/2015 - 07/2004
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2007 - 09/2006
1	Disease Progression 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Rett Syndrome (Rett's Disorder) 01/2018
1	Myoclonus (Nocturnal Myoclonus) 01/2018
1	Neurodevelopmental Disorders 01/2018
1	Angelman Syndrome (Syndrome, Angelman) 01/2017
1	Autistic Disorder (Autism) 01/2016
1	Acute Pain 01/2015

Drug/Important Bio-Agent (IBA)

20	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016 - 01/2002
16	NeurosteroidsIBA 01/2020 - 01/2002
15	Pregnanolone (Allopregnanolone)IBA 01/2022 - 07/2004
10	Pharmaceutical PreparationsIBA 01/2020 - 06/2004
8	ganaxoloneIBA 10/2018 - 01/2002
8	GABA-A Receptors (GABA(A) Receptor)IBA 10/2018 - 07/2004
7	AMPA Receptors (AMPA Receptor)IBA 01/2021 - 01/2010
7	Pentylenetetrazole (Metrazol)IBA 01/2018 - 06/2005
7	Ionotropic Glutamate ReceptorsIBA 03/2011 - 04/2003
6	BenzodiazepinesIBA 01/2021 - 04/2009
6	perampanelIBA 01/2021 - 03/2011
6	Diazepam (Valium)FDA LinkGeneric 01/2021 - 01/2010
5	Pilocarpine (Ocusert)FDA LinkGeneric 07/2017 - 06/2005
5	Kainic Acid (Kainate)IBA 01/2017 - 06/2004
5	gamma-Aminobutyric Acid (GABA)IBA 01/2013 - 01/2002
4	tetramethylenedisulfotetramine (DSTA)IBA 12/2021 - 05/2012
4	Midazolam (Versed)FDA LinkGeneric 12/2021 - 10/2013
4	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2021 - 06/2004
4	Kainic Acid Receptors (Kainate Receptor)IBA 04/2014 - 04/2003
4	Topiramate (Topamax)FDA LinkGeneric 08/2009 - 04/2003
4	Gluk1 kainate receptorIBA 08/2009 - 04/2003
3	Isoflurophate (DFP)FDA Link 11/2020 - 01/2016
3	OrganophosphatesIBA 11/2020 - 01/2020
3	Carbamazepine (Tegretol)FDA LinkGeneric 02/2015 - 06/2004
3	Sodium Channels (Sodium Channel)IBA 02/2015 - 07/2004
3	Ion Channels (Ion Channel)IBA 05/2013 - 01/2007
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2011 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2007
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
2	AlbuminsIBA 12/2019 - 01/2018
2	Isoflurane FDA LinkGeneric 01/2018 - 09/2004
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2016 - 01/2013
2	PicrotoxinIBA 02/2015 - 05/2002
2	Epoxide HydrolasesIBA 12/2014 - 01/2013
2	AcidsIBA 08/2012 - 08/2009
2	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2011 - 01/2002
2	tetrahydrodeoxycorticosteroneIBA 07/2011 - 05/2002
2	Progesterone FDA LinkGeneric 04/2009 - 03/2003
2	SteroidsIBA 10/2006 - 06/2005
2	Glutamate Receptors (Glutamate Receptor)IBA 06/2004 - 06/2004
2	N-Methylaspartate (NMDA)IBA 06/2004 - 06/2004
1	Atropine FDA LinkGeneric 11/2020
1	Nerve AgentsIBA 11/2020
1	fluoro-jade CIBA 11/2020
1	pralidoxime (Protopam Chloride)FDA Link 11/2020
1	Drug CombinationsIBA 11/2020
1	Blood Proteins (Serum Proteins)IBA 12/2019
1	Aminobutyrates (Aminobutyric Acid)IBA 10/2018
1	Losartan (Cozaar)FDA LinkGeneric 01/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Methyl-CpG-Binding Protein 2IBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2017
1	LigandsIBA 10/2016
1	KetonesIBA 01/2016
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2016
1	Neuroprotective AgentsIBA 01/2016
1	CalciumIBA 08/2015
1	Phenytoin (Dilantin)FDA LinkGeneric 02/2015
1	BicucullineIBA 02/2015
1	Lacosamide FDA Link 02/2015
1	Formaldehyde (Formol)FDA Link 01/2015
1	thiouredopyrenetrisulfonateIBA 12/2014
1	General AnestheticsIBA 12/2014
1	PropionatesIBA 04/2014
1	GluK2 Kainate ReceptorIBA 04/2014

Therapy/Procedure

15	Therapeutics 12/2021 - 06/2002
5	Ketogenic Diet 02/2016 - 09/2006
3	Drug Therapy (Chemotherapy) 01/2016 - 06/2002
3	Intravenous Infusions 04/2007 - 06/2004
2	Aftercare (After-Treatment) 01/2021 - 05/2012
1	Transcranial Magnetic Stimulation 01/2021
1	Topical Administration 01/2018
1	Lasers (Laser) 01/2017
1	Ligation 01/2015